| For: | Vij M, Calderaro J. Pathologic and molecular features of hepatocellular carcinoma: An update. World J Hepatol 2021; 13(4): 393-410 [PMID: 33959223 DOI: 10.4254/wjh.v13.i4.393] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/393.htm |
| Number | Citing Articles |
| 1 |
Celine Talley, Melissa Zolnierz, Bradley Creamer, Robert Hillard. Metastasis of hepatocellular carcinoma to the lungs and Virchow node or metachronous/synchronous tumors? A case report. Translational Research in Anatomy 2023; 32 doi: 10.1016/j.tria.2023.100254
|
| 2 |
C. H. A. Saler, S. Shuai, J. C. Beckervordersandforth, D. Rennspiess, G. Roemen, T. Gevers, M. C. F. Stoehr‐Kleinegris, S. A. W. Bouwense, M. J. L. Dewulf, M. M. E. Coolsen, M. H. A. Bemelmans, S. W. Olde Damink, V. Winnepenninckx, A. zur Hausen, M. Kramer, I. V. Samarska. Clinicopathological Study on Morphological Subtypes of Hepatocellular Carcinoma: A Single Tertiary Referral Center Experience. Cancer Reports 2025; 8(2) doi: 10.1002/cnr2.70127
|
| 3 |
Lobna Elkhadragy, Maximillian J. Carlino, Luke R. Jordan, Thomas Pennix, Nahed Ismail, Grace Guzman, Jonathan P. Samuelson, Lawrence B. Schook, Kyle M. Schachtschneider, Ron C. Gaba. Development of a genetically tailored implantation hepatocellular carcinoma model in Oncopigs by somatic cell CRISPR editing. Disease Models & Mechanisms 2025; 18(1) doi: 10.1242/dmm.052079
|
| 4 |
Yuanjie Liu, Elena S. Kim, Haitao Guo. Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures. Journal of Medical Virology 2024; 96(2) doi: 10.1002/jmv.29485
|
| 5 |
Shuyi Hu, Xiajie Lyu, Weifeng Li, Xiaohan Cui, Qiaoyu Liu, Xiaoliang Xu, Jincheng Wang, Lin Chen, Xudong Zhang, Yin Yin, Yuvaraja Teekaraman. Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC). Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/7693631
|
| 6 |
A. Meurgey, S. Mulé, G. Amaddeo, F. Pigneur, M. Djabbari, A. Galletto, B. Zegai, R. Kharrat, A. Laurent, J. Calderaro, A. Luciani, É. Reizine. Lésions hépatiques graisseuses : ce que tout radiologue devrait savoir. Journal d'imagerie diagnostique et interventionnelle 2023; 6(5) doi: 10.1016/j.jidi.2023.04.003
|
| 7 |
Deepinder Sharma, Lei Zhao. Pathology of Liver and Biliary Neoplasms. Hematology/Oncology Clinics of North America 2026; doi: 10.1016/j.hoc.2026.05.001
|
| 8 |
Mukul Vij, Jagadeesh Menon, Komalavalli Subbiah, Lexmi Priya Raju, Gowripriya Gowrisankar, Naresh Shanmugum, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Pathologic and Immunophenotypic Characterization of Syncytial Giant Cell Variant of Pediatric Hepatocellular Carcinoma. A Distinct Subtype. Fetal and Pediatric Pathology 2023; 42(4) doi: 10.1080/15513815.2023.2201318
|
| 9 |
Annabelle Chung, David Nasralla, Alberto Quaglia. Understanding the Immunoenvironment of Primary Liver Cancer: A Histopathology Perspective. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S382310
|
| 10 |
Akinpelu Moronkeji, Temidayo Daniel Adeniyi. Methane - Innovations for a Sustainable Future. 2025; doi: 10.5772/intechopen.1011758
|
| 11 |
Hui Qu, Shuairan Zhang, Xuedan Li, Yuan Miao, Yuxi Han, Ronghui Ju, Xiaoyu Cui, Yiling Li. A deep learning model based on self-supervised learning for identifying subtypes of proliferative hepatocellular carcinoma from dynamic contrast-enhanced MRI. Insights into Imaging 2025; 16(1) doi: 10.1186/s13244-025-01968-w
|
| 12 |
Edoardo Poli, Eleonora De Martin. Progression of liver disease and associated risk of hepatocellular carcinoma. Hepatoma Research 2024; doi: 10.20517/2394-5079.2023.101
|
| 13 |
Deniz Seyhan, Manon Allaire, Yaojie Fu, Filomena Conti, Xin Wei Wang, Bin Gao, Fouad Lafdil. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy. Cellular & Molecular Immunology 2025; 22(10) doi: 10.1038/s41423-025-01308-4
|
| 14 |
Liang Meng Loy, Hsien Min Low, Jin-Young Choi, Hyungjin Rhee, Chin Fong Wong, Cher Heng Tan. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review. American Journal of Roentgenology 2022; 219(2) doi: 10.2214/AJR.21.26982
|
| 15 |
Mukul Vij, Fadl H. Veerankutty, Lexmi Priya Raju, Gowripriya Gowrishankar, Rajesh Rajalingam, Dinesh Jothimani, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Frequent expression of PD-L1 in lymphocyte-rich hepatocellular carcinoma: A report of 4 cases. Annals of Diagnostic Pathology 2023; 66 doi: 10.1016/j.anndiagpath.2023.152172
|
| 16 |
Neda Zarrin-Khameh, Maryam Mohammadkhani, M. Lisa Zhang. Gross Pathology Atlas. 2026; doi: 10.1016/B978-0-443-36360-3.00044-4
|
| 17 |
М.Т. Orucov, E.T. Şamdancı, Ə.B. Həsənov. ФИБРОЛАМЕЛЛЯРНАЯ ГЕПАТОЦЕЛЛЮЛЯРНАЯ КАРЦИНОМА. Azerbaijan Medical Journal 2023; (3) doi: 10.34921/amj.2023.3.028
|
| 18 |
Maria Kotsari, Vassiliki Dimopoulou, John Koskinas, Athanasios Armakolas. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411471
|
| 19 |
Yao Chen, Qiang Zhang, Ming-Yang Zhang. Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis. World Journal of Gastroenterology 2026; 32(5): 113592 doi: 10.3748/wjg.v32.i5.113592
Abstract(92) |
Core Tip(63) |
Full Article(HTML)(1009)
|
Full Article (PDF)-6855K(81)
|
Full Article with Cover (PDF)-8374K(879)
|
Full Article (XML)-330K(32)
|
Audio-9524K(11)
|
Peer-Review Report-165K(41)
|
Answering Reviewers-329K(41)
|
Supplementary Material-1271K(35)
|
Times Cited (0)
|
Total Visits (2092)
|
Open
|
| 20 |
V.S. Trifanov, V.V. Kopylov, N.A. Grishin, N.N. Volchenko, M.E. Malushkova, A.A. Troitsky, R.I. Moshurov, S.I. Poluektov, M.V. Kosogolov. Hepatocellular carcinoma associated with nonalcoholic fatty liver disease. P.A. Herzen Journal of Oncology 2024; 13(6) doi: 10.17116/onkolog20241306157
|
| 21 |
Yingzheng Gao, Jiahao Chen, Weidong Du. Identification of novel potential biomarkers using bulk RNA and single cells to build a neural network model for diagnosis of liver cancer. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02420-7
|
| 22 |
Elisabeth Amadeo, Silvia Foti, Silvia Camera, Federico Rossari, Mara Persano, Federica Lo Prinzi, Francesco Vitiello, Andrea Casadei-Gardini, Margherita Rimini. Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents. Expert Opinion on Investigational Drugs 2024; 33(8) doi: 10.1080/13543784.2024.2377321
|
| 23 |
Saugata Sen, Anisha Gehani, Priya Ghosh, Anurima Patra, Sumit Mukhopadhyay, Aditi Chandra, Dayananda Lingegowda, Jeevitesh Khoda, Argha Chatterjee. Pathological Basis of Imaging in Hepatocellular Carcinoma. Journal of Gastrointestinal and Abdominal Radiology 2023; 6(03) doi: 10.1055/s-0043-1764310
|
| 24 |
Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Chih-Yun Lin, Alessandro Granito. Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies. PLOS ONE 2024; 19(3) doi: 10.1371/journal.pone.0290523
|
| 25 |
Hui Qu, Shuairan Zhang, Miaoran Guo, Yuan Miao, Yuxi Han, Ronghui Ju, Xiaoyu Cui, Yiling Li. Deep Learning Model for Predicting Proliferative Hepatocellular Carcinoma Using Dynamic Contrast-Enhanced MRI: Implications for Early Recurrence Prediction Following Radical Resection. Academic Radiology 2024; 31(11) doi: 10.1016/j.acra.2024.04.028
|
| 26 |
Romain Donne, Amaia Lujambio. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 2023; 77(5) doi: 10.1002/hep.32740
|
| 27 |
Xiaoming Li, Qiandong Yao, Chen Liu, Jian Wang, Huarong Zhang, Shiguang Li, Ping Cai. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S364742
|
| 28 |
Emine Turkmen Samdanci. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99842
|
| 29 |
Edouard Reizine, Azure Meurgey, Giuliana Amaddeo, Alexis Laurent, Julien Calderaro, Sebastien Mule, Alain Luciani. Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?. Abdominal Radiology 2022; 47(7) doi: 10.1007/s00261-022-03561-x
|
| 30 |
Giovanni A. Roldan, Jacquelin Blomker, Elizabeth S. Aby. Hepatocellular Carcinoma from a Hepatologist's Perspective. Seminars in Interventional Radiology 2023; 40(06) doi: 10.1055/s-0043-1777846
|
| 31 |
Jinlei Mao, Yuhang Tao, Keke Wang, Hanru Sun, Manqi Zhang, Liang Jin, Yi Pan. Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1371990
|
| 32 |
Swarna Bharathi Kalli, Nagaraju Bandaru, Hemanth Kumar Gorubala, Nalla Swathi, Mohan Gandi Bonthu, Bandla Aswani. Theranostics in Cancer Management. 2026; doi: 10.1016/B978-0-443-34199-1.00003-X
|
| 33 |
Pietro Guerra, Gianmarco Villano, Claudia M. Rejano-Gordillo, Clàudia Gil-Pitarch, Mariagrazia Ruvoletto, Alessandra Biasiolo, Santina Quarta, L. Estefanía Zapata-Pavas, Patricia Peña-SanFelix, Irene González-Recio, Naroa Goikoetxea-Usandizaga, Jon Ander Barrenechea-Barrenechea, Arantza Sanz-Parra, Alessandro Gambella, Silvia De Siervi, Barbara Oliviero, Stefania Mantovani, Jessica Nurcis, Silvia Cagnin, Andrea Martini, Cristian Turato, Stefania Cannito, Maria Guido, Maurizio Parola, María Luz Martínez-Chantar, Patrizia Pontisso. Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism. British Journal of Cancer 2026; 135(2) doi: 10.1038/s41416-026-03427-9
|
| 34 |
Mukul Vij, Lexmi Priya Raju, Dinesh Jothimani, Evangeline Simon, Subathra Radhakrishnan, Catherine Ann Martin, Gowripriya Gowrishankar, Komalavalli Subbiah, Rajesh Rajalingam, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Granuloma rich hepatocellular carcinoma (GrHCC): Clinicopathologic and genomic characterization. Annals of Diagnostic Pathology 2025; 79 doi: 10.1016/j.anndiagpath.2025.152504
|
| 35 |
Edoardo Poli, Marc-Antoine Allard, Astrid Laurent-Bellue, Maïté Lewin, Catherine Guettier, Daniel Azoulay, Audrey Coilly, Alexandre Dos Santos, Jamila Faivre, Eric Vibert, Alina Pascale, Clara Prud’homme, Antonio Sa Cunha, Faouzi Saliba, Jean Charles Duclos-Vallée, René Adam, Didier Samuel, Daniel Cherqui, Olivier Rosmorduc. Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation. Livers 2025; 5(1) doi: 10.3390/livers5010009
|
| 36 |
Si-yu Jing, Xue-liang Li, Hong Wen, Jing-xuan Cai, Yong-qi Bei, Xue-lian Zhao, Zheng-tao Zhang, Xiao-han Fan, Yi-ning Zou, Ling-li Chen, Yu-lin Wang, Cai-ying Wang, Xin Li, Li-li Meng, Ping Lin, Xi Yan, Yuan Ji, Hong Li. Multimodal AI model for early detection of hepatocellular carcinoma. npj Precision Oncology 2026; 10(1) doi: 10.1038/s41698-026-01393-2
|
| 37 |
Zartasha Rehman, Mariam Naveed, Bushra Ijaz, Muhammad Musaddiq Shah, Imran Shahid, Mohammad Tarique Imam, Ziyad Saeed Almalki, Sidra Rehman. Evaluation of betanin-encapsulated biopolymeric nanoparticles for antitumor activity via PI3K/Akt/mTOR signaling pathway. Arabian Journal of Chemistry 2023; 16(12) doi: 10.1016/j.arabjc.2023.105323
|
| 38 |
Priyanka Bhagat, Mukul Vij, Lexmi Priya Raju, Gowripriya Gowrishankar, Jagadeesh Menon, Naresh Shanmugam, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Update on the Pathology of Pediatric Liver Tumors: A Pictorial Review. Diagnostics 2023; 13(23) doi: 10.3390/diagnostics13233524
|
| 39 |
Ying Ge, Junjun Li, Chen Ming, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu. Proteomic and Transcriptomic Analyses Define Molecular Subtypes, Identify Biomarkers, and Suggest Potential Therapeutic Agent for Early-Stage HBV-Related Hepatocellular Carcinoma. Journal of Proteome Research 2025; 24(12) doi: 10.1021/acs.jproteome.5c00828
|
| 40 |
Sumit Kumar Vishwakarma. Correlation of Morphological Alterations and Genetic Expressions in Hepatocellular Carcinoma: A Clinico-Pathological Study in the Indian Population.. International Journal for Clinical Anatomy and Research 2026; doi: 10.66715/ijcar/2026v2.i1.2736
|
| 41 |
Subathra Radhakrishnan, Catherine Ann Martin, Mukul Vij, Komalavalli Subbiah, Lexmi Priya Raju, Gowripriya Gowrishankar, Vidya Harini Veldore, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma. Immunotherapy 2024; 16(6) doi: 10.2217/imt-2023-0243
|
| 42 |
Alexandru Blidisel, Iasmina Marcovici, Dorina Coricovac, Florin Hut, Cristina Adriana Dehelean, Octavian Marius Cretu. Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective. Cancers 2021; 13(15) doi: 10.3390/cancers13153651
|
| 43 |
Mehmet A. KOSEKLI, Gulali AKTAS. Pathogenesis, diagnosis and management of chronic hepatitis B related liver fibrosis. Minerva Gastroenterology 2025; 71(3) doi: 10.23736/S2724-5985.25.03862-8
|
| 44 |
Kathryn J. Fowler, Victoria Chernyak, Maxime Ronot, Valerie Vilgrain, Azusa Kitao, Jeong Min Lee, Utaroh Motosugi, Bin Song, Hanyu Jiang, Claude B. Sirlin, Mustafa R. Bashir. Hepatocellular Carcinoma: It Is Time to Focus on Prognosis. Radiology 2023; 307(3) doi: 10.1148/radiol.220884
|
| 45 |
Umut Cinar, Rengul Cetin Atalay, Yasemin Yardimci Cetin. Human Hepatocellular Carcinoma Classification from H&E Stained Histopathology Images with 3D Convolutional Neural Networks and Focal Loss Function. Journal of Imaging 2023; 9(2) doi: 10.3390/jimaging9020025
|
| 46 |
Alejandro Nieto Dominguez, Sarah Elizabeth Eichinger, Elza Matrova, Anas Almoghrabi. Adult Hepatoblastoma and Concomitant Hepatitis B Infection. ACG Case Reports Journal 2024; 11(9) doi: 10.14309/crj.0000000000001491
|
| 47 |
Marshal Dhayal, Shubhangi Srivastava, Juhi Jaiswal. Electrodeposited folic acid platinum electrode for rapid detection of human hepatocellular carcinoma cells. Electroanalysis 2024; 36(1) doi: 10.1002/elan.202200482
|
| 48 |
Qian Wang. Targeted therapy for liver cancer: Current status and future directions. BioImpacts 2025; 15 doi: 10.34172/bi.32630
|